Company · CIK 1825367

# RayzeBio, Inc.

| CIK | [1825367](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001825367) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2023-11-13 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-274193 | IPO Final prospectus | 2023-08-24 | 2023-09-18 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-09-18 | [424B4](https://www.sec.gov/Archives/edgar/data/1825367/000119312523237010/0001193125-23-237010-index.htm) Final prospectus | 333-274193 | 0001193125-23-237010 |
| 2023-09-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1825367/999999999523002665/9999999995-23-002665-index.htm) Declared effective | 333-274193 | 9999999995-23-002665 |
| 2023-09-11 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1825367/000119312523231908/0001193125-23-231908-index.htm) Amendment | 333-274193 | 0001193125-23-231908 |
| 2023-08-24 | [S-1](https://www.sec.gov/Archives/edgar/data/1825367/000119312523220093/0001193125-23-220093-index.htm) Registration filed | 333-274193 | 0001193125-23-220093 |
| 2022-02-11 | [DRS](https://www.sec.gov/Archives/edgar/data/1825367/000095012322002178/0000950123-22-002178-index.htm) Draft made public | 377-06008 | 0000950123-22-002178 |

[All filings of this company](https://equitycapital.markets/filings?cik=1825367) · [CSV](https://equitycapital.markets/filings.csv?cik=1825367)

---
Source page: https://equitycapital.markets/company/1825367 · Data: U.S. SEC EDGAR · CC BY 4.0